Japan's SBC Medical Q3 revenue beats, helped by higher patient volume and spend
SBC•SBC Medical's fiscal third-quarter revenue rose 35% to $59 million, beating the $48.89 million analyst estimate. Net income attributable to the company increased 22%, while adjusted EBITDA rose 66% and its margin expanded to 47%.
1. Revenue and earnings growth
SBC Medical reported fiscal third-quarter revenue of $59 million, up 35% year over year and above the $48.89 million analyst estimate. Net income attributable to the company grew 22%, and adjusted EBITDA rose 66%, with its margin expanding to 47%.
2. Patient and clinic growth
The company said patient visits increased 9% year over year and average spend per visit rose 4%. Its clinic network grew by 36 locations to 293, while higher management services revenue also reflected service fee structure revisions announced in August.
3. Investment plans
SBC Medical said it intends to direct cash toward disciplined growth investment to sustain medium- to long-term EPS growth. It plans to expand its clinic network and international presence, including in ASEAN markets, and is investing in AI and technology to improve clinic profitability and the efficiency of new openings.
